Inappropriate use of intravenous epinephrine leading to atrial fibrillation during prehospital anaphylaxis treatment: a case report

Article information

Clin Exp Emerg Med. 2024;.ceem.23.129
Publication date (electronic) : 2024 January 29
doi :
1Department of Emergency Medicine, Kyungpook National University School of Medicine, Daegu, Korea
2Armed Forces Medical Readiness and Training School, Daejeon, Korea
3Division of Allergy and Clinical Immunology, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea
Correspondence to: Hyun Wook Ryoo Department of Emergency Medicine, Kyungpook National University School of Medicine, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Korea Email:
Received 2023 September 13; Revised 2023 October 17; Accepted 2023 October 18.


In a prehospital setting, the narrow therapeutic window of epinephrine necessitates its cautious administration to avoid anaphylaxis. In this case, a 46-year-old man presented with severe anaphylactic symptoms. Following the standard protocol, the emergency medical technician (EMT) administered intramuscular epinephrine; however, symptoms persisted. Under the oversight of the emergency medical services (EMS) medical director, an additional intravenous bolus of epinephrine was administered, unfortunately leading to atrial fibrillation. This case underscores the potential risks of intravenous epinephrine, which is not typically recommended for anaphylaxis without continuous monitoring. Since 2019, Korea has initiated a pilot program to expand the EMT scope of practice, which gives them the authority to administer epinephrine for anaphylaxis. The ultimate decision regarding epinephrine use for anaphylaxis, emphasizing patient safety, rests with the EMS medical director. Proper training for EMTs, coupled with the EMS medical director’s comprehensive knowledge and meticulous protocol adherence, can ensure patient safety and optimal outcomes.


Epinephrine, a sympathomimetic agonist acting on α and β adrenergic receptors, exerts direct effects on various target organs. Among the multiple actions of epinephrine, its effects on α1 adrenergic receptors, including vasoconstriction, increasing peripheral vascular resistance, and decreasing mucosal edema, as well as its effects on β2 adrenergic receptors, including increasing bronchodilation and decreasing mediator release by mast cells and basophils, are crucial in anaphylaxis treatment [1]. Epinephrine has been widely used as a first-line drug for anaphylaxis, and its dosage and administration have been documented in several studies [13]. If appropriate treatment is not promptly administered, anaphylaxis can progress to a fatal condition; therefore, it is necessary to administer epinephrine before arriving at the hospital, as soon as possible [4].

However, administration of drug concentrations above the therapeutic range can result in pharmacological side effects, such as anxiety, fear, and headache; moreover, rare occurrences of ventricular arrhythmias, myocardial infarction, pulmonary edema, and cerebral hemorrhage have been reported [5].

In this case report, we present a case where inappropriate intravenous epinephrine administration led to atrial fibrillation in prehospital anaphylaxis patient treatment.


A 46-year-old man presented with respiratory distress, which prompted a call to the public emergency medical services (EMS). The caregiver of the patient reported that he had no significant past medical history or known allergies. On the day of the incident, the patient had visited a primary care facility for sore throat and was prescribed amoxicillin, acetaminophen, pseudoephedrine, ambroxol, and levocetirizine, which were taken at home. Subsequently, dyspnea developed. The patient was found lying on the living room floor by EMS in a drowsy mental state. Vital signs were as follows: blood pressure, 70/40 mmHg; pulse rate, 91 beats/min (bpm); respiratory rate, 14 breaths/min; body temperature, 36 °C; and oxygen saturation (room air), 96%. Emergency medical technicians (EMTs) diagnosed anaphylaxis based on physical examination and assessment results. Under the EMS medical director’s oversight, the EMTs administered 0.5 mg of intramuscular epinephrine (1:1,000) without using an autoinjector and provided 1 L of normal saline, 12 minutes after initial patient contact. Ten minutes following intramuscular epinephrine administration, symptoms had not improved. The vital signs were as follows: blood pressure, 63/27 mmHg, indicating persistent hypotension; pulse rate, 74 bpm; respiratory rate, 18 breaths/min; and oxygen saturation, 99%. Direct medical oversight was requested again, and the EMS medical director instructed a bolus injection of 0.5 mg intravenous epinephrine (1:1,000). One minute following bolus intravenous epinephrine administration, the patient complained of chest pain and palpitations, with the following vital signs: blood pressure, 189/84 mmHg and pulse rate, 179 bpm. After 5 minutes, the patient was transported to the emergency department of a nearby tertiary hospital and immediately moved to the resuscitation room. Upon hospital admission, the patient reported chest discomfort but no other symptoms. His vital signs were as follows: blood pressure, 132/98 mmHg; heart rate, 108 bpm; respiratory rate, 22 breaths/min; temperature, 36.2 °C; and oxygen saturation (room air), 97%. Electrocardiogram (ECG) revealed atrial fibrillation with a heart rate of 101 bpm (Fig. 1). Initial laboratory data showed normal complete blood count, elevated lactic acid level (1.9 mmol/L), and normal high-sensitive cardiac troponin I (hs-cTnI) level (<2.5 pg/mL). Three hours following admission, the hs-cTnI level increased to 141 pg/mL. The patient continued to complain of chest discomfort, and a follow-up ECG confirmed atrial fibrillation with a rapid ventricular rate (Fig. 2). Consequently, amiodorone was administered, which resulted in conversion to a sinus rhythm (Fig. 3). Afterward, the patient did not report any specific discomfort and remained hemodynamically stable with normal blood pressure and without refractory hypotension. The patient was discharged after one day of observation in the hospital, during which he complained of no specific discomfort and his vital signs remained stable. Follow-up ECG revealed a normal sinus rhythm, and the hs-cTnI level decreased to 61.01 pg/mL. Transthoracic echocardiography was performed, which showed no significant cardiac structure abnormalities. One week following discharge, a drug hypersensitivity test performed in the outpatient department showed a positive result for penicillin allergy, confirming that the anaphylaxis episode was triggered by the amoxicillin administration.

Fig. 1.

Initial electrocardiogram at the time of hospital admission. Atrial fibrillation was noted. HR, heart rate; QTc, corrected QT.

Fig. 2.

Electrocardiogram performed 3 hours after hospital admission. Atrial fibrillation with rapid ventricular response was revealed. HR, heart rate; QTc, corrected QT.

Fig. 3.

Electrocardiogram performed after administration of amiodarone showed conversion to normal sinus rhythm. HR, heart rate; QTc, corrected QT.

Ethics statement

The requirement for informed consent from the patient was waived for this case report by the Institutional Review Board of Kyungpook National University Hospital (No. KNUH-2023-08-005).


In anaphylaxis management, epinephrine is recommended as the promptly administered first-line drug. For teenagers and adults, intramuscular administration of a dose of 0.01 to 0.5 mg/kg of body weight (1:1,000) of epinephrine is recommended [2,3]. If symptoms are refractory, repeat doses can be administered at 5- to 15-minute intervals. Most patients respond to one or two doses [2,3]. Intravenous epinephrine bolus administration is not routinely recommended as it can induce fatal arrhythmias [2,3,68]. A case of cardiac arrest occurred following intravenous administration of 0.3 mg epinephrine (1:1,000) in a patient with computed tomography contrast-induced anaphylaxis [9]. In a study comparing routes of epinephrine administration in anaphylaxis, intravenous bolus epinephrine had significantly higher risk of overdose and adverse cardiovascular events compared to intramuscular epinephrine administration [6]. However, if used, intravenous epinephrine should be administered by healthcare professionals with experience in diluting and administering correct doses using an infusion pump for monitored patients [3].

Anaphylaxis caused by allergic reactions requires immediate intervention to prevent progression to a fatal condition. Patients with a known history of allergies may have access to an epinephrine autoinjector. However, in cases of initial allergic reactions or reactions triggered by environmental factors, immediate treatment of symptoms may not be possible and initial management may be performed by EMS [10]. In situations where the transportation time to the hospital is short, one or two doses of medication may be sufficient, reducing the need for additional interventions. However, it is essential to be prepared in cases where the transportation time exceeds the timeframe of one or two intramuscular epinephrine doses, and knowledge on the management of anaphylaxis unresponsive to epinephrine administration may be necessary. EMTs play multiple roles from assessing the patient to providing initial treatment and facilitating transport [11]. A previous meta-analysis [12] showed a low rate of epinephrine use in the prehospital setting owing to the fear of potential adverse effects associated with epinephrine injection.

In Korea, the use of epinephrine by EMTs in the prehospital phase for patients with anaphylaxis was legally prohibited. However, due to the necessity of prehospital epinephrine administration in patients with anaphylaxis, a pilot program was initiated in 2019. This project, organized by the Ministry of Health and Welfare and the National Fire Agency, aimed to evaluate the safety of patients following an expansion of EMTs’ scope of practice. Under the EMS medical directors’ oversight through video medical guidance, EMTs who completed education in advanced cardiovascular life support involving epinephrine use in anaphylaxis were permitted to administer epinephrine via an autoinjector to patients with anaphylaxis when deemed necessary. The implementation of this program sought to ensure patient safety while expanding the responsibilities of EMTs [13].

Additional interventions by the EMS medical director would be needed in cases of anaphylaxis, wherein some patients are unresponsive to the initial treatment. A case was reported in Australia [14] wherein an error following intramuscular epinephrine administration by EMTs led to inadvertent administration of 5 mg intravenous epinephrine, which resulted in ventricular tachycardia. In our case, under the medical director’s oversight, EMTs administered not only 0.5 mg of epinephrine intramuscularly without using an autoinjector, but also an intravenous epinephrine bolus. There were discrepancies with the established guidelines for prehospital anaphylaxis treatment. Administering an intravenous epinephrine bolus, even without mentioning deviation from the guideline, was also incorrect. The correct approach involves administering a diluted dose slowly over 5 to 10 minutes in a closely monitored hospital setting [8]. In the prehospital phase, there are limitations in terms of personnel and confined spaces where medical interventions must be performed, which may hinder real-time feedback and communications. To address this, training on the optimal anaphylaxis treatments for EMTs and EMS medical director's sufficient knowledge and careful instruction regarding epinephrine use are necessary. Additionally, adherence to guidelines is crucial.


Author contributions

Conceptualization: HWR; Formal analysis: HJ, JHL, SHC; Investigation: JP, JHL, SHC; Methodology: HWR, HJ; Project administration: HWR, JP; Resources: HWR, SK; Validation: HWR, SK; Software: HJ; Supervision: HWR, SK; Visualization: HJ; Writing–original draft: HJ; Writing–review & editing: all authors. All authors read and approved the final manuscript.

Conflicts of interest

The authors have no conflicts of interest to declare.


The authors received no financial support for this study.

Data availability

Data sharing is not applicable as no new data were created or analyzed in this study.


1. Sheikh A, Shehata YA, Brown SG, Simons FE. Adrenaline for the treatment of anaphylaxis: cochrane systematic review. Allergy 2009;64:204–12.
2. Cardona V, Ansotegui IJ, Ebisawa M, et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J 2020;13:100472.
3. Muraro A, Worm M, Alviani C, et al. EAACI guidelines: anaphylaxis (2021 update). Allergy 2022;77:357–77.
4. Brown JC, Simons E, Rudders SA. Epinephrine in the management of anaphylaxis. J Allergy Clin Immunol Pract 2020;8:1186–95.
5. Simons FE. First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol 2004;113:837–44.
6. Campbell RL, Bellolio MF, Knutson BD, et al. Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine. J Allergy Clin Immunol Pract 2015;3:76–80.
7. LoVerde D, Iweala OI, Eginli A, Krishnaswamy G. Anaphylaxis. Chest 2018;153:528–43.
8. Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and grading of recommendations, assessment, development and evaluation (GRADE) analysis. J Allergy Clin Immunol 2020;145:1082–123.
9. Pathangey G, Moudgal R, Lee C, Henkin S. Myocardial stunning secondary to erroneous administration of intravenous epinephrine. SAGE Open Med Case Rep 2023;11:2050313X231159732.
10. Casale TB, Wang J, Oppenheimer J, Nowak-Wegrzyn A. Acute at-home management of anaphylaxis: 911: what is the emergency? J Allergy Clin Immunol Pract 2022;10:2274–9.
11. Fineman SM, Bowman SH, Campbell RL, et al. Addressing barriers to emergency anaphylaxis care: from emergency medical services to emergency department to outpatient follow-up. Ann Allergy Asthma Immunol 2015;115:301–5.
12. Miles LM, Ratnarajah K, Gabrielli S, et al. Community use of epinephrine for the treatment of anaphylaxis: a review and meta-analysis. J Allergy Clin Immunol Pract 2021;9:2321–33.
13. Lee H, Kwon JW, Jeong YW, Lee C, Lee J. Pilot project of special emergency medical service team for anaphylaxis in Gangwon-do, Korea: results from an online questionnaire survey. J Korean Med Sci 2021;36:e258.
14. Callum J, Rivlin M, Carroll P. Intravenous epinephrine overdose in prehospital management of suspected anaphylaxis. BMJ Case Rep 2020;13e232654.

Article information Continued


Capsule Summary

What is already known

Epinephrine is the primary treatment for anaphylaxis, but incorrect administration can cause serious complications.

What is new in the current study

This case report highlights a rare complication of inappropriate intravenous epinephrine administration leading to atrial fibrillation in prehospital anaphylaxis management. Emphasizing the need for rigorous training and cautious oversight, it underscores the imperative of optimal protocol adherence by both emergency medical technicians and emergency medical services medical directors in anaphylaxis treatment.

Fig. 1.

Initial electrocardiogram at the time of hospital admission. Atrial fibrillation was noted. HR, heart rate; QTc, corrected QT.

Fig. 2.

Electrocardiogram performed 3 hours after hospital admission. Atrial fibrillation with rapid ventricular response was revealed. HR, heart rate; QTc, corrected QT.

Fig. 3.

Electrocardiogram performed after administration of amiodarone showed conversion to normal sinus rhythm. HR, heart rate; QTc, corrected QT.